Regeneron beats quarterly estimates on eczema drug demand; launches dividend program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. XPEV
4. AAPL
5. BMO
6. VEEV
7. MU
8. CJMB
9. REAX
10. NYAX

Go back to Regeneron beats quarterly estimates on eczema drug demand; launches dividend program
Regeneron (NASDAQ: REGN) Delayed: 833.67 +5.17 (0.62%)
Previous Close $828.50    52 Week High $592.36 
Open $828.63    52 Week Low $325.35 
Day High $833.67    P/E 218.81 
Day Low $823.44    EPS $3.81 
Volume 22,829